Korro Bio (KRRO) Enterprise Value (2019 - 2025)
Korro Bio (KRRO) has disclosed Enterprise Value for 6 consecutive years, with -$92.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value fell 42.33% year-over-year to -$92.5 million, compared with a TTM value of -$92.5 million through Sep 2025, down 42.33%, and an annual FY2024 reading of -$126.1 million, up 25.7% over the prior year.
- Enterprise Value was -$92.5 million for Q3 2025 at Korro Bio, up from -$96.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$40.9 million in Q1 2023 and bottomed at -$194.9 million in Q1 2021.
- Average Enterprise Value over 5 years is -$98.9 million, with a median of -$93.0 million recorded in 2024.
- The sharpest move saw Enterprise Value skyrocketed 74.91% in 2022, then crashed 248.44% in 2024.
- Year by year, Enterprise Value stood at -$130.7 million in 2021, then skyrocketed by 57.73% to -$55.2 million in 2022, then plummeted by 207.18% to -$169.7 million in 2023, then rose by 25.7% to -$126.1 million in 2024, then increased by 26.66% to -$92.5 million in 2025.
- Business Quant data shows Enterprise Value for KRRO at -$92.5 million in Q3 2025, -$96.4 million in Q2 2025, and -$64.1 million in Q1 2025.